Skip to content

Cotrimoxazole study opens door to new public health programmes targeting all children with HIV

Four days of nevirapine plus a month of 2 NRTIs appears to be ‘safe’ PEP strategy

HIV-related diabetes: a complex interaction between liver damage, body mass and genetics?

Dendritic-cell treatment boosts therapeutic vaccine prospects

Two Cipla antiretrovirals return to WHO prequalification list

Women and girls must have equal access to HIV treatment, say WHO and UNAIDS

Can HIV infection occur through the lining of the mouth?

Tipranavir expanded access programme begins in US

Injecting drug users more likely to die when taking HAART, but HIV not the reason

High incidence of IRIS amongst HIV-positive TB patients starting HAART in India

HAART and adverse events during pregnancy explored in European study

Involvement of partner in VCT increases uptake of interventions to prevent vertical and sexual HIV transmission

Drug-resistant virus acquired during HIV infection remains stable and persistent

WHO guidelines for treatment of diarrhoea in HIV patients may need revising in some settings, says study

Risky sex leads to treatment optimism, not the other way round, finds study

Pre-treatment HIV severity, not HAART associated with peripheral neuropathy

500mg Invirase tablet approved in the US

Combination of antibiotics as effective and safe as co-trimoxazole at preventing infections, but too expensive to use where needed?